Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
American Journal of Clinical Dermatology|March 4, 2020
Long-Term Outcomes in BRAF-Mutated Melanoma Treated with Combined Targeted Therapy or Immune Checkpoint Blockade: Are We Approaching a True Cure?Patrick Schummer, Bastian Schilling, Anja GesierichFrontiers in Immunology|December 20, 2024
Re-exposition to ipilimumab plus nivolumab in metastatic Merkel cell carcinomaValerie Glutsch, Patrick Schummer, Matthias Goebeler, et al.Cancer Biology & Therapy|April 7, 2016
Specific c-Jun target genes in malignant melanomaPatrick Schummer, Silke Kuphal, Lily Vardimon, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 13, 2025
Brentuximab vedotin as monotherapy or combination therapy for cutaneous peripheral T cell lymphoma - a retrospective studyCaroline Glatzel, Inga Hansen-Abeck, Nina Booken, et al.Cancers|November 11, 2022
Panel Sequencing of Primary Cutaneous B-Cell LymphomaMarion Wobser, Patrick Schummer, Silke Appenzeller, et al.Melanoma Research|May 22, 2018
Early onset of diffuse melanosis cutis under pembrolizumab therapy illustrates the limitations of anti-PD-1 checkpoint inhibitorsAlexander Thiem, Patrick Schummer, Simon Ueberschaar, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 30, 2025
Brentuximab vedotin and radiotherapy for CD30-positive cutaneous T-cell lymphoma - a retrospective multicenter analysisPatrick Schummer, Caroline Glatzel, Philipp Schrüfer, et al.Acta Dermato-Venereologica|January 20, 2026
Perioperative Pembrolizumab in Locally Advanced Melanoma: A Real-world Single-centre Retrospective StudySimon Goller, Tassilo Dege, Patrick Schummer, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 2, 2022
Patient Preferences in Hidradenitis Suppurativa (APProach-HS): a discrete choice experimentKristin Faverio, Wiebke K Peitsch, Tatiana Görig, et al.Patient Preference and Adherence|April 9, 2026
Patient Preferences in Hidradenitis Suppurativa Depend on Treatment Experience: Results from APProach-HSChristian Kromer, Kristin Faverio, Tatiana Görig, et al.Pageof 2